20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T4280 | Gcase activator 1 | LTI-291,LTI 291,LTI291 | Glucosidase |
Gcase activator 1 (LTI-291) is a glucocerebrosidase (Gcase) activator. | |||
T82330 | GCase modulator-1 | Glucosidase | |
GCase Modulator-1 (Compound 9g), a quinazoline derivative, functions as a glucosidase modulator with an AC50 value of 2.23 µM [1]. | |||
T78573 | Glucocerebrosidase | GCase,Glucosylceramidase | Endogenous Metabolite |
Glucocerebrosidase (Glucosylceramidase; GBA), a lysosomal enzyme, catalyzes the hydrolysis of the β-glucosidic linkage in glucocerebroside (GC) to yield glucose and ceramide [1]. | |||
T8986 | ML198 | Glucokinase | |
ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase. ML198 serves as a starting point to develop a novel approach towards small molecule treatment for patients suffering from Gaucher disease. | |||
T0920 | Ambroxol | Ambroxolum,NA-872 | P450 , Autophagy |
Ambroxol (NA-872) is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It is the active ingredient of Mucosolvan, Lasolvan or Mucoangin. The substance is a muco... | |||
T6234 | Ambroxol hydrochloride | Mucosolvan,Mucoangin,Ambroxol HCl | Sodium Channel , Autophagy |
Ambroxol hydrochloride (Mucosolvan) is a metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride. | |||
T75407 | Endoglycoceramidase I (EGCase I) | ||
Endoglycoceramidase I (EGCase I), a glycosidase frequently utilized in biochemical studies, catalyzes a transglycosylation reaction. This process involves transferring the sugar moiety of GSLs to the primary hydroxyl gro... | |||
T75406 | Endoglycoceramidase II (EGCase II) | ||
Endoglycoceramidase II (EGCase II), an endo-β-glucosidase, catalyzes the hydrolysis of the β-glycosidic linkage between oligosaccharides and ceramides in glycosphingolipids, releasing the complete glycan from ceramide [1... | |||
T8989 | NCGC 607 | NCGC607 | Others |
NCGC 607 is a a noninhibitory chaperone of glucocerebrosidase (GCase). | |||
T8990 | ML266 | Glucokinase | |
ML266, a glucocerebrosidase (GCase) chaperone with an IC50 of 2.5 µM, facilitates the transport of the mutant protein to the lysosome, thereby restoring GCase activity without inhibiting the enzyme's function. This compo... | |||
TQ0300 | Conduritol B epoxide | Glucosidase | |
Conduritol B epoxide is an irreversible inhibitor of β-glucosidase (GCase). | |||
T39518 | PFB-FDGlu | Others | |
PFB-FDGlu is a lysosomal Glucocerebrosidase (GCase) substrate with cell-permeable specificity that is cleaved to produce fluorescein.PFB-FDGlu is often used in conjunction with a flow cytometer to measure GCase activity ... | |||
T35626 | AMP-Deoxynojirimycin | AMP-DNM | Transferase , Glucosidase |
AMP-Deoxynojirimycin (AMP-DNM) is a potent inhibitor of ceramide glucosyltransferase and GCase 2.AMP-Deoxynojirimycin is a potent inhibitor of GlcCer biosynthesis and is used in the study of Parkinson's and diabetes. | |||
T37571 | 4-Methylumbelliferyl-β-D-Glucopyranoside | MU-GLU,4-MUG,4-MU-GLU,4-MU-β-Gluc | Others |
4-Methylumbelliferyl-β-D-Glucopyranoside (4-MU-GLU) is used in the GCase activity assay based on the catalytic hydrolysis of 4-methylumbelliferyl β-D-glucopyranoside that releases the highly fluorescent 4-methylumbellife... | |||
T71476 | Afegostat TFA | ||
Afegostat, aslo known as Isofagomine, and AT2101, was an experimental drug for the treatment of certain forms of Gaucher's disease. Isofagomine (IFG) is an acid β-glucosidase (GCase) active site inhibitor that acts as a ... | |||
T19182 | Afegostat D-Tartrate | Isofagomine D-Tartrate,D-Isofagomine D-Tartrate | Others |
Afegostat D-Tartrate is a pharmacological chaperone that specifically and reversibly binds acid-β-glucosidase (GCase) in the endoplasmic reticulum with high affinity. | |||
T60353 | Glucocerebrosidase-IN-1 | ||
Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC 50 of 29.3 μM and a K i of 18.5 μM. Due to GCase involvement in pathological disorders consequent to enzym... | |||
T23653 | Afegostat HCl | Afegostat,AT-2101,Afegostat hydrochloride,AT2101 | |
Afegostat is an acid β-glucosidase (GCase) active site inhibitor that acts as a pharmacological chaperone. Afegostat inhibits GCase with K(i) ~30 nM for wild-type and mutant enzymes. Afegostat was an experimental drug fo... | |||
T19181 | Afegostat | D-Isofagomine,Isofagomine | Others |
Afegostat is a pharmacological chaperone that specifically and reversibly binds acid-β-glucosidase (GCase) in the endoplasmic reticulum with high affinity. | |||
T78671 | Glucocerebrosidase-IN-1 hydrochloride | Glucosidase | |
Glucocerebrosidase-IN-1 (compound 11a) hydrochloride is a potent, selective GCase (glucocerebrosidase) inhibitor with IC50 and Ki values of 29.3 μM and 18.5 μM, respectively. It is utilized in the research of Gaucher dis... |